MSF in Mozambique 2001-2010: Ten years of HIV projects

In the late 1990s, the introduction of antiretroviral (ARV) treatment transformed AIDS from a death sentence to a chronic lifelong disease. However, the extremely high cost of ARV drugs meant that treatment was restricted to people in richer parts of the world, and the millions of people suffering from the disease in places like Africa remained untreated. National and international decision makers actively refrained from embarking on the fight against HIV/AIDS, believing that an insufficient budget and a scarcity of both technical means and human resources would lead to inadequate HIV care and management. Their fear was that this would ultimately lead to the emergence of widespread drug-resistant strains of the virus, which would exacerbate an already dire situation.